Neural stem cells (NSC) derived from human parthenogenic stem cells (hpSC) have been observed to show stronger positive functional effects than hpSC-derived dopaminergic neuron precursors (DAP) in treatment of induced Parkinson Disease in animal models. RNAseq of the two types of cells were normalized and analyzed to compare gene expression profiles. SOURCE: Robert,E,Morey (robmoreyucsd@gmail.com) - Laurent UCSD

Pluto Bioinformatics

GSE52912: Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors.